H100 ™
Authentic H100 ™ Gel, created by Hybrid Medical, is available only from PD Labs and must be dispensed from PD Labs directly to your patient.
Developing H100 ™ to find a Peyronie’s disease (PD) treatment that could help men suffering from Acute phase/stage disease when PD is developing. Peyronie’s disease involves a cascade of events in which trauma leads to inflammation, which leads to scar tissue development. Changing the natural course of this cascade was the focus of our research.
This Peyronie’s disease treatment should target inflammation, scar tissue remodeling, and plaque development. As documented in prior independent studies, Nicardipine and Superoxide dismutase can accomplish this. To ensure these ingredients are delivered deep within the tissue, not just on the surface, we combined these ingredients with ultra-purified emu oil. It contains the fatty acids necessary to be an effective carrier agent.
The results have been positive, statistically improving penile curvature, stretched penile length, and pain reduction. Rash was the only side effect in about 10% of patients.
Maximum benefit was seen after six months of treatment with H100 ™, though many patients noted improvement after three months of H100 ™ Peyronie’s disease treatment. Every person reacts differently to different treatments. Patients usually try H100 ™ for three months and, if they remain stable or improve, then continue for a total of six months.
To read about the H100™ study, click here.
Prescribing authentic H100™ Gel can be accomplished in one of two simple ways:
Fax a prescription to PD Labs at 1-866-687-2217. PD Labs can provide pre-printed fax forms to simplify the process upon request.
Call in a verbal prescription to PD Labs at 1-800-687-9014.
PD Labs will contact the patient upon receipt of the prescription to answer questions about the medication, counsel the patient on the proper use of the medication, describe possible side effects, and arrange for payment and shipping of the medication. Written detailed instructions and informational materials are provided to all patients upon filling their prescription. A PD Labs pharmacist will review all patient information before filling the prescription and will contact the physician and patient if there are any contraindications or concerns (more contraindication and side effect information here). PD Labs counsels every patient on the proper use of the medication and establishes monitoring parameters regarding the patient’s condition so that a pharmacist may follow up with the patient on the drug’s effectiveness.
Please be sure to include your patient’s demographic information with their prescription to help expedite the ordering process.
Abstract of H100 ™ Published Clinical Study Results
Int J Impot Res. 2016 Mar-Apr;28(2):41-5. doi: 10.1038/ijir.2015.22. Epub 2015 Dec 24.
Topical treatment for acute phase Peyronie’s disease utilizing a new gel, H-100™: a randomized, prospective, placebo-controlled pilot study.
Twidwell J, Levine L.
Abstract
Safety and efficacy of topically applied gel H100™ composed of Nicardipine, superoxide dismutase and emu oil for treatment of acute phase Peyronie’s disease (PD) was evaluated. Twenty-two patients (PD <12 months duration) were studied in a prospective, randomized, double-blind, placebo-controlled study. Eleven patients received H100™ and 11 patients received placebo for 3 months. All 22 patients then received H100™ for the final 3 months. Flaccid-stretched penile length, degree of penile curvature, pain level and side effects were assessed monthly. H100™ showed significant improvement in all PD parameters at 6 months: mean stretched penile length increase (22.6%, P=0.0002), mean curvature reduction (40.8%, P=0.0014), and mean pain level reduction (85.7%, P=0.004). Placebo group showed no significant improvement except for mean stretched penile length increase (6.8%, P=0.009). Crossover patients from placebo to H-100 showed significant improvement in all parameters: mean stretched penile length increase (17.5%, P=0.000007), mean curvature reduction (37.1%, P=0.006), and mean pain level reduction (40%, P=0.17). Treatment was well tolerated. A self-limited rash was the only side effect in three patients. Statistically significant improvements in flaccid-stretched penile length, curvature and pain suggest that H100 is a safe and possibly effective non-invasive, topically applied treatment for acute phase Peyronie’s Disease.
The study size was relatively small, but its design was done under the guidance of Dr. Larry Levine, a world expert in Peyronie’s Disease. Due to H100’s mechanism of action, the study only included acute phase patients with developing disease.
Based on our study, maximum benefit was seen after six months of treatment with H100, though many patients noted improvement after three months of treatment. (1)
A skin rash in the area of application is the only known side effect or adverse reaction in about 10% of patients with H100 use.
No compounded medication is reviewed by the FDA for safety and efficacy.
Important Note: H100 gel is only meant to be applied topically as directed for treatment of Peyronie’s disease. It is not intended for any other use. Do NOT take it orally, by injection or through any other method of delivery. For best results, always follow prescribing directions carefully.
